Copyright Reports & Markets. All rights reserved.

Global Arginase Deficiency Treatment Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Arginase Deficiency Treatment Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Arginase Deficiency Treatment Market Size Growth Rate by Product
      • 1.4.2 Oral
      • 1.4.3 Injection
    • 1.5 Market by End User
      • 1.5.1 Global Arginase Deficiency Treatment Market Size Growth Rate by End User
      • 1.5.2 Hospital
      • 1.5.3 Drugs Stores
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Arginase Deficiency Treatment Market Size
      • 2.1.1 Global Arginase Deficiency Treatment Revenue 2014-2025
      • 2.1.2 Global Arginase Deficiency Treatment Sales 2014-2025
    • 2.2 Arginase Deficiency Treatment Growth Rate by Regions
      • 2.2.1 Global Arginase Deficiency Treatment Sales by Regions
      • 2.2.2 Global Arginase Deficiency Treatment Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Arginase Deficiency Treatment Sales by Manufacturers
      • 3.1.1 Arginase Deficiency Treatment Sales by Manufacturers
      • 3.1.2 Arginase Deficiency Treatment Sales Market Share by Manufacturers
      • 3.1.3 Global Arginase Deficiency Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Arginase Deficiency Treatment Revenue by Manufacturers
      • 3.2.1 Arginase Deficiency Treatment Revenue by Manufacturers (2014-2019)
      • 3.2.2 Arginase Deficiency Treatment Revenue Share by Manufacturers (2014-2019)
    • 3.3 Arginase Deficiency Treatment Price by Manufacturers
    • 3.4 Arginase Deficiency Treatment Manufacturing Base Distribution, Product Types
      • 3.4.1 Arginase Deficiency Treatment Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Arginase Deficiency Treatment Product Type
      • 3.4.3 Date of International Manufacturers Enter into Arginase Deficiency Treatment Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Arginase Deficiency Treatment Sales by Product
    • 4.2 Global Arginase Deficiency Treatment Revenue by Product
    • 4.3 Arginase Deficiency Treatment Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Arginase Deficiency Treatment Breakdown Data by End User

    6 North America

    • 6.1 North America Arginase Deficiency Treatment by Countries
      • 6.1.1 North America Arginase Deficiency Treatment Sales by Countries
      • 6.1.2 North America Arginase Deficiency Treatment Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Arginase Deficiency Treatment by Product
    • 6.3 North America Arginase Deficiency Treatment by End User

    7 Europe

    • 7.1 Europe Arginase Deficiency Treatment by Countries
      • 7.1.1 Europe Arginase Deficiency Treatment Sales by Countries
      • 7.1.2 Europe Arginase Deficiency Treatment Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Arginase Deficiency Treatment by Product
    • 7.3 Europe Arginase Deficiency Treatment by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Arginase Deficiency Treatment by Countries
      • 8.1.1 Asia Pacific Arginase Deficiency Treatment Sales by Countries
      • 8.1.2 Asia Pacific Arginase Deficiency Treatment Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Arginase Deficiency Treatment by Product
    • 8.3 Asia Pacific Arginase Deficiency Treatment by End User

    9 Central & South America

    • 9.1 Central & South America Arginase Deficiency Treatment by Countries
      • 9.1.1 Central & South America Arginase Deficiency Treatment Sales by Countries
      • 9.1.2 Central & South America Arginase Deficiency Treatment Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Arginase Deficiency Treatment by Product
    • 9.3 Central & South America Arginase Deficiency Treatment by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Arginase Deficiency Treatment by Countries
      • 10.1.1 Middle East and Africa Arginase Deficiency Treatment Sales by Countries
      • 10.1.2 Middle East and Africa Arginase Deficiency Treatment Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Arginase Deficiency Treatment by Product
    • 10.3 Middle East and Africa Arginase Deficiency Treatment by End User

    11 Company Profiles

    • 11.1 Helsinn Healthcare
      • 11.1.1 Helsinn Healthcare Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Helsinn Healthcare Arginase Deficiency Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Helsinn Healthcare Arginase Deficiency Treatment Products Offered
      • 11.1.5 Helsinn Healthcare Recent Development
    • 11.2 Novartis Pharmaceuticals
      • 11.2.1 Novartis Pharmaceuticals Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Novartis Pharmaceuticals Arginase Deficiency Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Novartis Pharmaceuticals Arginase Deficiency Treatment Products Offered
      • 11.2.5 Novartis Pharmaceuticals Recent Development
    • 11.3 Horizo​​n Pharma
      • 11.3.1 Horizo​​n Pharma Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Horizo​​n Pharma Arginase Deficiency Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Horizo​​n Pharma Arginase Deficiency Treatment Products Offered
      • 11.3.5 Horizo​​n Pharma Recent Development
    • 11.4 Medicis Pharmaceutical
      • 11.4.1 Medicis Pharmaceutical Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Medicis Pharmaceutical Arginase Deficiency Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Medicis Pharmaceutical Arginase Deficiency Treatment Products Offered
      • 11.4.5 Medicis Pharmaceutical Recent Development

    12 Future Forecast

    • 12.1 Arginase Deficiency Treatment Market Forecast by Regions
      • 12.1.1 Global Arginase Deficiency Treatment Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Arginase Deficiency Treatment Revenue Forecast by Regions 2019-2025
    • 12.2 Arginase Deficiency Treatment Market Forecast by Product
      • 12.2.1 Global Arginase Deficiency Treatment Sales Forecast by Product 2019-2025
      • 12.2.2 Global Arginase Deficiency Treatment Revenue Forecast by Product 2019-2025
    • 12.3 Arginase Deficiency Treatment Market Forecast by End User
    • 12.4 North America Arginase Deficiency Treatment Forecast
    • 12.5 Europe Arginase Deficiency Treatment Forecast
    • 12.6 Asia Pacific Arginase Deficiency Treatment Forecast
    • 12.7 Central & South America Arginase Deficiency Treatment Forecast
    • 12.8 Middle East and Africa Arginase Deficiency Treatment Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Arginase Deficiency Treatment Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Argininemia, also called arginase deficiency, is an autosomal recessive urea cycle disorder where adeficiency of the enzyme arginase causes a buildup of arginine and ammonia in the blood.
      The global Arginase Deficiency Treatment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Arginase Deficiency Treatment market based on company, product type, end user and key regions.

      This report studies the global market size of Arginase Deficiency Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Arginase Deficiency Treatment in these regions.
      This research report categorizes the global Arginase Deficiency Treatment market by top players/brands, region, type and end user. This report also studies the global Arginase Deficiency Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Helsinn Healthcare
      Novartis Pharmaceuticals
      Horizo​​n Pharma
      Medicis Pharmaceutical

      Market size by Product
      Oral
      Injection
      Market size by End User
      Hospital
      Drugs Stores
      Other

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Arginase Deficiency Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Arginase Deficiency Treatment market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Arginase Deficiency Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Arginase Deficiency Treatment submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Arginase Deficiency Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Arginase Deficiency Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now